These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7303134

  • 41. Relationship between intensity of infection and immunomodulation in human schistosomiasis. I. Lymphocyte subpopulations and specific antibody responses.
    Feldmeier H, Gastl GA, Poggensee U, Kortmann C, Daffalla AA, Peter HH.
    Clin Exp Immunol; 1985 May; 60(2):225-33. PubMed ID: 3159526
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Serological speciation of human schistosome infections by ELISA with a panel of three antigens.
    Turner P, Lalloo K, Bligh J, Armstrong M, Whitty CJ, Doenhoff MJ, Chiodini PL.
    J Clin Pathol; 2004 Nov; 57(11):1193-6. PubMed ID: 15509682
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Single dose oral treatment in urinary schistosomiasis: a double blind trial.
    Pugh RN, Teesdale CH.
    Br Med J (Clin Res Ed); 1983 Feb 05; 286(6363):429-32. PubMed ID: 6401550
    [Abstract] [Full Text] [Related]

  • 46. Schistosoma haematobium in Upper Egypt: analysis of dispersion patterns.
    Kitron UD, Higashi GI.
    Am J Trop Med Hyg; 1985 Mar 05; 34(2):331-40. PubMed ID: 3985275
    [Abstract] [Full Text] [Related]

  • 47. Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children.
    Naus CW, van Dam GJ, Kremsner PG, Krijger FW, Deelder AM.
    Clin Infect Dis; 1998 May 05; 26(5):1142-7. PubMed ID: 9597243
    [Abstract] [Full Text] [Related]

  • 48. [Comparative efficacy of oltipraz (1 dose, 30 mg/kg) and the combination of niridazole (25 mg/kg) and metrifonate (10 mg/kg) against S. haematobium].
    Rey JL, Sellin E, Sellin B, Simonkovich E, Mouchet F.
    Med Trop (Mars); 1984 May 05; 44(2):155-8. PubMed ID: 6482729
    [Abstract] [Full Text] [Related]

  • 49. Suppression of mitogen-induced lymphocyte transformation by plasma from patients with hepatosplenic Schistosomiasis mansoni: role of immune complexes.
    Kamal KA, Higashi GI.
    Parasite Immunol; 1982 Jul 05; 4(4):283-98. PubMed ID: 6812000
    [Abstract] [Full Text] [Related]

  • 50. Present situation of schistosomiasis in the Libyan Arab Republic. I. Bilharziasis in Ubari District in Fezzan (Sebha Governorate.
    El-Gíndy MS, El-Edríssy AW.
    Egypt J Bilharz; 1975 Jul 05; 2(1):117-30. PubMed ID: 1181169
    [Abstract] [Full Text] [Related]

  • 51. Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection.
    Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M.
    Eur J Immunol; 1996 Jun 05; 26(6):1365-70. PubMed ID: 8647218
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Treatment of Schistosoma hematobium infestation with niridazol].
    Ehrlich D, Bar-Meir S, Master R, Levin H, Itzhak J, Hillel T.
    Harefuah; 1973 Jul 15; 85(2):83-4. PubMed ID: 4730988
    [No Abstract] [Full Text] [Related]

  • 54. Circulating soluble antigens and antibody in schistosomiasis.
    Madwar MA, Voller A.
    Br Med J; 1975 Feb 22; 1(5955):435-6. PubMed ID: 123165
    [Abstract] [Full Text] [Related]

  • 55. Study of cell mediated immune responsiveness to soluble egg antigen and phytohaemagglutinin using the lymphoblast transformation test in human schistosomiasis mansoni in Egypt.
    Khalil H, Fahmy MH, Ghanem MH, Said M, El Sawy M, Nofal M, Awadalla HN, Youssef M, Mucke D, Brock J, Bedwany R, Khalil T.
    Rev Inst Med Trop Sao Paulo; 1981 Feb 22; 23(3):97-101. PubMed ID: 7280480
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. IgG and IgE circulating immune complexes, total serum IgE and parasite related IgE in patients with mono- or mixed infection with Schistosoma mansoni and/or S. haematobium. Influence of therapy.
    Stevens WJ, Feldmeir H, Bridts CH, Daffalla AA.
    Clin Exp Immunol; 1983 Apr 22; 52(1):144-52. PubMed ID: 6861371
    [Abstract] [Full Text] [Related]

  • 58. Immune responses to a soluble schistosomal egg antigen preparation during chronic primary infection with Schistosoma mansoni.
    Colley DG.
    J Immunol; 1975 Jul 22; 115(1):150-6. PubMed ID: 1171139
    [Abstract] [Full Text] [Related]

  • 59. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum.
    Zinyowera S, Muchaneta-Kubara CE, Mutapi F, Midzi N, Ndlovu PD, Mduluza T.
    Cent Afr J Med; 2006 Jul 22; 52(9-12):104-11. PubMed ID: 20353134
    [Abstract] [Full Text] [Related]

  • 60. Efficacy and mechanism of action of arachidonic acid in the treatment of hamsters infected with Schistosoma mansoni or Schistosoma haematobium.
    El Ridi R, Tallima H, Salah M, Aboueldahab M, Fahmy OM, Al-Halbosiy MF, Mahmoud SS.
    Int J Antimicrob Agents; 2012 Mar 22; 39(3):232-9. PubMed ID: 22240411
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.